Did Treasury Target Pfizer-Allergan Inversion?
The Obama Administration and the Allergan CEO disagree about whether the government wanted specifically to kill the giant drug merger.
Signs of a Second-Quarter Rebound?
Orders for durable goods declined at a seasonally adjusted 0.5% in April, but excluding the transportation sector the numbers showed signs of life.
CFOs Collaborating More with Their CIOs
Finance chiefs' insufficient understanding of IT issues is still a major hurdle, though, says E&Y.